Pierre Jolicoeur, Ph.D. Email & Phone Number

Kirkland, Wa, Us

Kirkland, Wa, Us

Tampa, Florida, Us

Leveraging over 25 years of scientific and operational experience in the fields of bioanalysis, vaccines, and gene therapy, primarily in the contract research organization (CRO) industry. Using my unique track record to lead the development and implementation of strategies that will foster the growth and future trajectory of the company.

Wilmington, Nc, Us

OVERVIEW: Promoted onto the executive team and worked with C-suite leadership to promote new market development, expanding client base and technology platforms. Hold accountability for delivering on financial growth targets. Achieved and sustained double-digit growth, increasing lab capacity by 13-fold and staff size 10-fold over tenure.SELECT HIGHLIGHTS:-Enhanced PPD's presence in the vaccine services markets, positioning the company as an Industry leader through expansion of vaccine service capabilities-Participated in the development and implementation of global vaccine immunogenicity testing laboratories and services in Asia, overcoming region-specific challenges, including building, and collaborating with a team from abroad and helping to build a fully functional and complex operation from the ground up in a country that operates under different regulations and country-specific requirements-Collaborated with Business Development and Marketing to strategically promote vaccine capabilities

Wilmington, Nc, Us

OVERVIEW: Directed operations across the newly created Vaccine Sciences Department. Managed laboratory space expansion, hiring of additional staff, and multimillion-dollar financial resources. Oversaw quality, efficiency, and strategic planning. Provided scientific and technical leadership in the development and validation of cell and vaccine assays. SELECT HIGHLIGHTS:-Led start-up of department dedicated to supporting vaccine development, including sourcing, and recruiting multidisciplinary team composed of multiple scientific professionals-Spearheaded development of new markets, clients, and technologies within the field of vaccines, collaborating directly with the Business Development department to anticipate and proactively respond to industry needs-Recommended and implemented new cellular and vaccine-related technologies throughout the department-Secured successful FDA approval for several new vaccines

Wilmington, Nc, Us

OVERVIEW: Promoted to oversee the optimization of cell-based assay and vaccine operations across immunochemistry laboratories. Allocated resources, and managed facilities and personnel. Provided the necessary scientific and technical leadership for cell and vaccine assay development and validation. Graduated from the PPD Global Leadership Program.SELECT HIGHLIGHTS:-Expanded two innovative platforms:-First platform aims at determining efficacy of vaccines and the second focused on the detection of neutralizing antibodies against large therapeutic drug products-Spearheaded expansion of cell-based assay laboratories, as well as the construction of new vaccine facility, increasing laboratory capacity 5 times, to meet growing demand for vaccine support-Collaborated cross-functionally with Finance, Marketing, and Business Development to promote vaccine development support and cell-based assay (IM) services, achieving double-digit growth-Recognized with 2011 PPD CEO Leadership Excellence award for consistently delivering high quality and client-driven results, with demonstrated coaching and leadership across functions and levels of the organization

Wilmington, Nc, Us

OVERVIEW: Recruited to build and launch operational activities to support the implementation of two new services, bioanalytical (cell-based neutralizing antibody detection) and vaccine development. Worked with Business Development and Marketing to develop and promote new bioanalysis and vaccine services following successful program creation and launches.SELECT HIGHLIGHTS:-Oversaw construction for state-of-the art, high-throughput, vaccine-dedicated facility as well as the setup of cell-based assay laboratories -Sourced, recruited, and hired multidisciplinary team of 30 scientific professionals-Created and introduced end-to-end standard operating procedures (SOPs)-Managed technical transfer and validation of vaccine assays according to strict timelines and schedules, including on-time initiation of clinical vaccine studies and results-Initiated projects requiring development and validation of functional assays to detect presence of neutralizing antibodies to therapeutic proteins-Collaborated with Financial Services to establish pricing structure aligned with the development, validation, and testing of human clinical samples

King Of Prussia, Pennsylvania, Us

OVERVIEW: Coordinated Ligand Binding and Cellular Assay Services of the Department, overseeing a team of 55 supporting bioanalytical activities (IM, PK). Maintained accountability for growth and profitability of the department. SELECT HIGHLIGHTS:-Developed cell-based assay testing expertise, supporting IM studies for large therapeutic molecules

OVERVIEW: Supervised operations of the Custom Services Department related to the generation, purification, and amplification of adenovirus vectors for therapeutic and gene therapy applications. Focused on quality of services rendered, meeting deadlines, and excellence in client services.

Ottawa, Ontario, Ca

OVERVIEW: Held accountability for the development of assays and instruments (cell lines) for the generation of recombinant adenovirus and the expression of various proteins. Primary technologies used included cell engineering, molecular biology, flow cytometry, viral plate generation, viral titration, ELISA and protein expression and detection systems.

Ph.D., Microbiology And Immunology

M.Sc., Biology (Immunology/Microbiology)

B.Sc., Experimental Biology